Tonic immobility in guinea pigs: A behavioural response for detecting an anxiolytic-like effect?

Christina K. Olsen, S. Hogg, M. D S Lapiz

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Tonic immobility (TI) is considered to be an innate fear response characterized by a temporary state of profound and reversible motor inhibition. TI occurs in a wide range of species in a predator-prey confrontation and is hypothesized to be a terminal defence response occurring when there is physical contact between prey and predator. The objective of the present study was to investigate the validity of the TI model in guinea pigs for detection of anxiolytic and/or antidepressant drug activity. Compounds that reduced TI include the serotonin (5-HT) releaser fenfluramine, the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and buspirone, the 5-HT2C/2B receptor antagonist SB206553, the 5-HT2A receptor antagonist MDL 100.151 - but only at doses thought also to inhibit 5-HT2C receptors-the noradrenaline (NA) reuptake inhibitor desipramine, the benzodiazepine inverse agonist FG-7142, the α2-adrenergic receptor antagonist yohimbine, the neurokinin (NK)1 receptor antagonist L-733.060, and the NK2 receptor antagonist SR-48968. Compounds that increased TI include the benzodiazepine agonists diazepam and alprazolam, and the α2-adrenergic receptor agonist clonidine. The selective 5-HT reuptake inhibitors citalopram, paroxetine and fluoxetine, the 5-HT1A receptor antagonist WAY100.635, the 5-HT2C receptor agonist MK-212, the 5-HT/NA reuptake inhibitor imipramine, the NA reuptake inhibitor talopram, the benzodiazepine antagonist flumazenil, the α2-adrenergic receptor antagonist idazoxan and the psychostimulant amphetamine did not have any effect. These findings indicate that the serotonergic, noradrenergic and neurokinin systems are involved in mediating or modulating TI behaviour in guinea pigs. The potential of TI as a behaviour for detecting anxiolytic-like effect may be questioned due to the contradictory effect of the benzodiazepine ligands, which may be attributed to the sedative and/or ataxic effects of the compounds. Nevertheless, there is preclinical evidence suggesting that 5-HT1A receptor agonists, 5-HT2C receptor antagonists and NK1 and NK2 receptor antagonists possess anxiolytic potential. Only when results of clinical investigations of the anxiolytic potential of non-benzodiazepine ligands (for example the NK receptor antagonists) are available, will it be possible to determine fully the predictive validity of the TI model.

Original languageEnglish (US)
Pages (from-to)261-269
Number of pages9
JournalBehavioural Pharmacology
Volume13
Issue number4
StatePublished - Jul 2002
Externally publishedYes

Fingerprint

Receptor, Serotonin, 5-HT2C
Anti-Anxiety Agents
Benzodiazepines
Receptor, Serotonin, 5-HT1A
Serotonin
Guinea Pigs
Serotonin 5-HT1 Receptor Agonists
Serotonin 5-HT2 Receptor Antagonists
8-Hydroxy-2-(di-n-propylamino)tetralin
Norepinephrine
Adrenergic Antagonists
Serotonin 5-HT2 Receptor Agonists
Neurokinin-1 Receptor Antagonists
Serotonin 5-HT1 Receptor Antagonists
Idazoxan
Alprazolam
Ligands
Buspirone
Fenfluramine
Receptor, Serotonin, 5-HT2A

Keywords

  • Anxiety
  • Benzodiazepine ligands
  • Guinea pig
  • Neurokinin
  • Noradrenaline
  • Serotonin
  • Tonic immobility

ASJC Scopus subject areas

  • Pharmacology
  • Neuroscience(all)

Cite this

Tonic immobility in guinea pigs : A behavioural response for detecting an anxiolytic-like effect? / Olsen, Christina K.; Hogg, S.; Lapiz, M. D S.

In: Behavioural Pharmacology, Vol. 13, No. 4, 07.2002, p. 261-269.

Research output: Contribution to journalArticle

Olsen, Christina K. ; Hogg, S. ; Lapiz, M. D S. / Tonic immobility in guinea pigs : A behavioural response for detecting an anxiolytic-like effect?. In: Behavioural Pharmacology. 2002 ; Vol. 13, No. 4. pp. 261-269.
@article{6ad4bc38225046a7a49dfc28643d91e6,
title = "Tonic immobility in guinea pigs: A behavioural response for detecting an anxiolytic-like effect?",
abstract = "Tonic immobility (TI) is considered to be an innate fear response characterized by a temporary state of profound and reversible motor inhibition. TI occurs in a wide range of species in a predator-prey confrontation and is hypothesized to be a terminal defence response occurring when there is physical contact between prey and predator. The objective of the present study was to investigate the validity of the TI model in guinea pigs for detection of anxiolytic and/or antidepressant drug activity. Compounds that reduced TI include the serotonin (5-HT) releaser fenfluramine, the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and buspirone, the 5-HT2C/2B receptor antagonist SB206553, the 5-HT2A receptor antagonist MDL 100.151 - but only at doses thought also to inhibit 5-HT2C receptors-the noradrenaline (NA) reuptake inhibitor desipramine, the benzodiazepine inverse agonist FG-7142, the α2-adrenergic receptor antagonist yohimbine, the neurokinin (NK)1 receptor antagonist L-733.060, and the NK2 receptor antagonist SR-48968. Compounds that increased TI include the benzodiazepine agonists diazepam and alprazolam, and the α2-adrenergic receptor agonist clonidine. The selective 5-HT reuptake inhibitors citalopram, paroxetine and fluoxetine, the 5-HT1A receptor antagonist WAY100.635, the 5-HT2C receptor agonist MK-212, the 5-HT/NA reuptake inhibitor imipramine, the NA reuptake inhibitor talopram, the benzodiazepine antagonist flumazenil, the α2-adrenergic receptor antagonist idazoxan and the psychostimulant amphetamine did not have any effect. These findings indicate that the serotonergic, noradrenergic and neurokinin systems are involved in mediating or modulating TI behaviour in guinea pigs. The potential of TI as a behaviour for detecting anxiolytic-like effect may be questioned due to the contradictory effect of the benzodiazepine ligands, which may be attributed to the sedative and/or ataxic effects of the compounds. Nevertheless, there is preclinical evidence suggesting that 5-HT1A receptor agonists, 5-HT2C receptor antagonists and NK1 and NK2 receptor antagonists possess anxiolytic potential. Only when results of clinical investigations of the anxiolytic potential of non-benzodiazepine ligands (for example the NK receptor antagonists) are available, will it be possible to determine fully the predictive validity of the TI model.",
keywords = "Anxiety, Benzodiazepine ligands, Guinea pig, Neurokinin, Noradrenaline, Serotonin, Tonic immobility",
author = "Olsen, {Christina K.} and S. Hogg and Lapiz, {M. D S}",
year = "2002",
month = "7",
language = "English (US)",
volume = "13",
pages = "261--269",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Tonic immobility in guinea pigs

T2 - A behavioural response for detecting an anxiolytic-like effect?

AU - Olsen, Christina K.

AU - Hogg, S.

AU - Lapiz, M. D S

PY - 2002/7

Y1 - 2002/7

N2 - Tonic immobility (TI) is considered to be an innate fear response characterized by a temporary state of profound and reversible motor inhibition. TI occurs in a wide range of species in a predator-prey confrontation and is hypothesized to be a terminal defence response occurring when there is physical contact between prey and predator. The objective of the present study was to investigate the validity of the TI model in guinea pigs for detection of anxiolytic and/or antidepressant drug activity. Compounds that reduced TI include the serotonin (5-HT) releaser fenfluramine, the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and buspirone, the 5-HT2C/2B receptor antagonist SB206553, the 5-HT2A receptor antagonist MDL 100.151 - but only at doses thought also to inhibit 5-HT2C receptors-the noradrenaline (NA) reuptake inhibitor desipramine, the benzodiazepine inverse agonist FG-7142, the α2-adrenergic receptor antagonist yohimbine, the neurokinin (NK)1 receptor antagonist L-733.060, and the NK2 receptor antagonist SR-48968. Compounds that increased TI include the benzodiazepine agonists diazepam and alprazolam, and the α2-adrenergic receptor agonist clonidine. The selective 5-HT reuptake inhibitors citalopram, paroxetine and fluoxetine, the 5-HT1A receptor antagonist WAY100.635, the 5-HT2C receptor agonist MK-212, the 5-HT/NA reuptake inhibitor imipramine, the NA reuptake inhibitor talopram, the benzodiazepine antagonist flumazenil, the α2-adrenergic receptor antagonist idazoxan and the psychostimulant amphetamine did not have any effect. These findings indicate that the serotonergic, noradrenergic and neurokinin systems are involved in mediating or modulating TI behaviour in guinea pigs. The potential of TI as a behaviour for detecting anxiolytic-like effect may be questioned due to the contradictory effect of the benzodiazepine ligands, which may be attributed to the sedative and/or ataxic effects of the compounds. Nevertheless, there is preclinical evidence suggesting that 5-HT1A receptor agonists, 5-HT2C receptor antagonists and NK1 and NK2 receptor antagonists possess anxiolytic potential. Only when results of clinical investigations of the anxiolytic potential of non-benzodiazepine ligands (for example the NK receptor antagonists) are available, will it be possible to determine fully the predictive validity of the TI model.

AB - Tonic immobility (TI) is considered to be an innate fear response characterized by a temporary state of profound and reversible motor inhibition. TI occurs in a wide range of species in a predator-prey confrontation and is hypothesized to be a terminal defence response occurring when there is physical contact between prey and predator. The objective of the present study was to investigate the validity of the TI model in guinea pigs for detection of anxiolytic and/or antidepressant drug activity. Compounds that reduced TI include the serotonin (5-HT) releaser fenfluramine, the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and buspirone, the 5-HT2C/2B receptor antagonist SB206553, the 5-HT2A receptor antagonist MDL 100.151 - but only at doses thought also to inhibit 5-HT2C receptors-the noradrenaline (NA) reuptake inhibitor desipramine, the benzodiazepine inverse agonist FG-7142, the α2-adrenergic receptor antagonist yohimbine, the neurokinin (NK)1 receptor antagonist L-733.060, and the NK2 receptor antagonist SR-48968. Compounds that increased TI include the benzodiazepine agonists diazepam and alprazolam, and the α2-adrenergic receptor agonist clonidine. The selective 5-HT reuptake inhibitors citalopram, paroxetine and fluoxetine, the 5-HT1A receptor antagonist WAY100.635, the 5-HT2C receptor agonist MK-212, the 5-HT/NA reuptake inhibitor imipramine, the NA reuptake inhibitor talopram, the benzodiazepine antagonist flumazenil, the α2-adrenergic receptor antagonist idazoxan and the psychostimulant amphetamine did not have any effect. These findings indicate that the serotonergic, noradrenergic and neurokinin systems are involved in mediating or modulating TI behaviour in guinea pigs. The potential of TI as a behaviour for detecting anxiolytic-like effect may be questioned due to the contradictory effect of the benzodiazepine ligands, which may be attributed to the sedative and/or ataxic effects of the compounds. Nevertheless, there is preclinical evidence suggesting that 5-HT1A receptor agonists, 5-HT2C receptor antagonists and NK1 and NK2 receptor antagonists possess anxiolytic potential. Only when results of clinical investigations of the anxiolytic potential of non-benzodiazepine ligands (for example the NK receptor antagonists) are available, will it be possible to determine fully the predictive validity of the TI model.

KW - Anxiety

KW - Benzodiazepine ligands

KW - Guinea pig

KW - Neurokinin

KW - Noradrenaline

KW - Serotonin

KW - Tonic immobility

UR - http://www.scopus.com/inward/record.url?scp=0036633354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036633354&partnerID=8YFLogxK

M3 - Article

C2 - 12218506

AN - SCOPUS:0036633354

VL - 13

SP - 261

EP - 269

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 4

ER -